Discover the precision and consistency of the Supreme Peptides SLU-PP-332 Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “SLU-PP-332” and contains a premium synthetic peptide with purity exceeding 99%, ensuring reliable performance and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on metabolic signaling, energy utilization, and mitochondrial function. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of use in controlled research protocols.

SLU-PP-332 is a novel synthetic peptide analog studied for its role in activating pathways associated with mitochondrial biogenesis, fatty acid oxidation, and metabolic efficiency. In research settings, it has gained attention for its potential to mimic aspects of exercise-induced metabolic activity by influencing nuclear receptors involved in energy regulation and endurance signaling.

Product overview

SLU-PP-332 is a research-grade peptide engineered to interact with key metabolic regulators involved in cellular energy production. Preclinical research associates SLU-PP-332 with enhanced mitochondrial function, increased oxidative capacity, and improved metabolic flexibility in experimental models. Its unique mechanism makes it a valuable research tool for studying endurance, fat metabolism, and energy balance.

Key research features

Mitochondrial and energy metabolism research:
SLU-PP-332 is widely studied for its potential to stimulate mitochondrial biogenesis and oxidative phosphorylation. Research models explore its ability to increase cellular energy efficiency and endurance-related signaling pathways.

Fat oxidation and metabolic efficiency:
Studies suggest SLU-PP-332 may enhance fatty acid utilization and reduce reliance on glucose under certain conditions, making it relevant in experimental research focused on fat loss, metabolic adaptation, and body composition dynamics.

Exercise-mimetic signaling pathways:
SLU-PP-332 has been investigated for its ability to activate nuclear receptors involved in exercise-responsive gene expression. This profile makes it particularly valuable in research models examining endurance, performance adaptation, and metabolic resilience.

SLU-PP-332 Suggested Use:

• Typical Dose: 250–500 mcg per injection

• Route: Subcutaneous or intramuscular

• Frequency: Once daily

• Duration: 4–6 weeks, or as recommended by a healthcare professional

Note: Always consult a healthcare professional before use. Keep out of reach of children.